1. AHA meeting - the latest from Lilly, Caladrius, Amgen, and more —FDA approves latest Humira biosimilar, this time from Pfizer — Alkermes acquiring Rodin Therapeutics — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Southwest

  1. General Discussion - Southwest

    Discussions:
    0
    Messages:
    0
    (Contains no messages)
    RSS